NCT02083315View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Pain, Acute
Interventions
DRUG

TRV130 1.5 mg

TRV130 1.5 mg IV x 1 dose

DRUG

TRV130 3 mg

TRV130 3 mg IV x 1 dose

DRUG

TRV130 4.5 mg

TRV130 4.5 mg IV x 1 dose

DRUG

Morphine 10 mg

Morphine 10 mg IV x 1 dose

DRUG

Placebo

Dextrose 5% in water IV x 1 dose

Trial Locations (1)

84106

CRI Lifetree, Salt Lake City

All Listed Sponsors
lead

Trevena Inc.

INDUSTRY

NCT02083315 - Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects | Biotech Hunter | Biotech Hunter